Elevated Serum MicroRNA Levels Associate with Absence of High-Grade Prostate Cancer in a Retrospective Cohort

To reduce treatment of indolent prostate cancer (PCa), biomarkers are needed to improve identification of patients with a low-risk of having aggressive disease. Over-treatment of these patients occurs because of uncertainty in the aggressiveness of the entire tumor based on the biopsies, which do no...

Descripción completa

Detalles Bibliográficos
Autores principales: Mihelich, Brittany L., Maranville, Joseph C., Nolley, Rosalie, Peehl, Donna M., Nonn, Larisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396984/
https://www.ncbi.nlm.nih.gov/pubmed/25874774
http://dx.doi.org/10.1371/journal.pone.0124245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396984/
https://www.ncbi.nlm.nih.gov/pubmed/25874774
http://dx.doi.org/10.1371/journal.pone.0124245

Ejemplares similares